Pricing Log in Create free account
Saturday 17 October 2026 Export DGX’s income statement to Excel — free account

Quest Diagnostics Incorporated

DGX Healthcare Diagnostics & Research

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS grew 14.7%, free cash flow grew 5.28% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

235.00 4.15 −1.74%
Market cap
$26.4B
P/E
24.6×
Fwd P/E
20.8×
Dividend yield
1.44%
F-score
8/9
Altman Z
3.15
Beneish M
−2.65
Dividend safety
85/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Quest Diagnostics Incorporated (DGX) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, Quest Diagnostics Incorporated (DGX) trades at a P/B ratio of 3.3×. Over the past ten years it has ranged from 1.7× (April 2020) to 3.5× (September 2026); the current reading is higher than 99% of that period. That is above the Diagnostics & Research industry median of 3.1× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 2.7× 8.75%
FY2024 2.5× (1.17%)
FY2023 2.5× (18.38%)
FY2022 3.0× (8.65%)
FY2021 3.3× 42.24%
FY2020 2.3× (6.80%)
FY2019 2.5× 17.03%
FY2018 2.2× (21.37%)
FY2017 2.7× (1.55%)
FY2016 2.8× 27.78%

Quarterly newest first

Period P/B ratio Change
Jun 2026 3.0× 7.00%
Mar 2026 2.8× 5.20%
Dec 2025 2.7× (8.65%)
Sep 2025 2.9× 5.66%
42 more quarters

Against its own ten years

Low 1.7× High 3.5×
Ten-year median 2.6×
Current reading's percentile 99

P/B ratio against peers

Company P/B ratio
GH Guardant Health, Inc. compare n/m
RVTY Revvity Inc. compare 2.4×
WAT Waters Corporation compare 2.8×
LH Labcorp Holdings Inc. compare 3.0×
DGX Quest Diagnostics Incorporated 3.3×
ILMN Illumina, Inc. compare 13.9×
IDXX IDEXX Laboratories, Inc. compare 27.4×
MEDP Medpace Holdings, Inc. compare 40.2×
MTD Mettler-Toledo International, Inc. compare 2,546×
Diagnostics & Research industry median 3.1×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on DGX